23 /100
LOW RISK
Score updated May 29, 2026

VYNE — VYNE Therapeutics Inc. Dilution Risk Tracker

Track VYNE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VYNE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.64 below $1 exchange minimum
🔔 Track VYNE — Get forecast alerts →

💹 Market Data

Market Cap$22.91M
Shares Outstanding33.35M
Float32.55M
Cash$24.93M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 114.6% shares (2025Q4 vs prior)
42 institutional holders · 8.44M shares
#1 Shay Capital LLC 1.62M shares
#2 Anson Funds Management LP 1.27M shares
#3 Nantahala Capital Management, LLC 1.00M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest120.7K
Days to Cover1.2
% of Float0.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2018
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track VYNE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VYNE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for VYNE
📊 VYNE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VYNE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.